The efficacy of botulinum toxin treatment for children with a persistent esotropia following bilateral medial rectus recessions and lateral rectus resections

Am Orthopt J. 2013:63:24-8. doi: 10.3368/aoj.63.1.24.

Abstract

Background and purpose: To report on the outcomes of treating children with a persistent esotropia with an injection of botulinum toxin in a medial rectus muscle.

Patients and methods: The medical records were reviewed of all children at one institution with a persistent esotropia after bilateral medial rectus recessions and bilateral lateral rectus resections then treated with a botulinum toxin injection.

Results: Five patients with a mean preoperative esotropia of 37Δ (range 25–50Δ) underwent bilateral medial rectus recessions and then bilateral lateral rectus resections. Their residual esotropia (mean of 25Δ; range 18–35Δ) was then treated with a single injection of 3–5 units of botulinum toxin into one medial rectus muscle. The patients were then followed for a mean of 34 months (range 14–79 months). At last follow-up, two patients had an esotropia <10Δ. The other three patients had no long-term improvement in their ocular alignment. Two of these patients then underwent additional strabismus surgery. In both cases, they then developed a consecutive exotropia.

Conclusion: Treatment with a single injection of botulinum toxin was beneficial in 2 of 5 children. Botulinum toxin treatment alone did not result in a consecutive exotropia in any patients treated.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Dyskinesia Agents / administration & dosage
  • Botulinum Toxins / administration & dosage*
  • Child
  • Esotropia / drug therapy*
  • Esotropia / etiology
  • Esotropia / physiopathology
  • Eye Movements
  • Follow-Up Studies
  • Humans
  • Injections, Intramuscular
  • Oculomotor Muscles / physiopathology
  • Oculomotor Muscles / surgery*
  • Ophthalmologic Surgical Procedures / adverse effects*
  • Retrospective Studies
  • Treatment Outcome
  • Vision, Binocular

Substances

  • Anti-Dyskinesia Agents
  • Botulinum Toxins